Noninvasive in vivo measuring system and noninvasive in vivo measuring method by correcting influence of Hemoglobin
First Claim
Patent Images
1. A noninvasive in vivo measuring system comprising:
- a tissue modulation unit configured to apply a pressure on a tissue;
a hemoglobin (Hb) measuring unit configured to analyze an amount of absorption of electromagnetic waves on a first portion of the tissue before and after the application of the pressure by the tissue modulation unit, and configured to measure a Hb concentration of the tissue; and
a Raman-fluorescence (R-F) measuring unit configured to measure a blood sugar concentration by analyzing Raman spectra based on a reflection of a laser irradiated on a second portion of the tissue before and after the application of the pressure by the tissue modulation unit, and configured to calculate a final blood sugar level by correcting the blood sugar concentration measurement, based on the measured Hb concentration,wherein the R-F measuring unit is configured to calculate the final blood sugar level by increasingly correcting the blood sugar concentration measurement, having been measured based on the Raman spectra, when the Hb concentration is greater than a predetermined threshold value, and is configured to calculate the final blood sugar level by decreasingly correcting the blood sugar concentration measurement, having been measured based on the Raman spectra, when the Hb concentration is less than the predetermined threshold value.
1 Assignment
0 Petitions
Accused Products
Abstract
A noninvasive in vivo measuring system and a noninvasive in vivo measuring method are provided. In the noninvasive in vivo measuring system, a Raman-fluorescence measuring unit measures blood sugar concentration, which is measured using Raman spectra before and after applying a pressure on a finger, and outputs a final blood sugar level by correcting the blood sugar concentration measurement according to a Hemoglobin (Hb) concentration measured by an Hb measuring unit.
-
Citations
18 Claims
-
1. A noninvasive in vivo measuring system comprising:
-
a tissue modulation unit configured to apply a pressure on a tissue; a hemoglobin (Hb) measuring unit configured to analyze an amount of absorption of electromagnetic waves on a first portion of the tissue before and after the application of the pressure by the tissue modulation unit, and configured to measure a Hb concentration of the tissue; and a Raman-fluorescence (R-F) measuring unit configured to measure a blood sugar concentration by analyzing Raman spectra based on a reflection of a laser irradiated on a second portion of the tissue before and after the application of the pressure by the tissue modulation unit, and configured to calculate a final blood sugar level by correcting the blood sugar concentration measurement, based on the measured Hb concentration, wherein the R-F measuring unit is configured to calculate the final blood sugar level by increasingly correcting the blood sugar concentration measurement, having been measured based on the Raman spectra, when the Hb concentration is greater than a predetermined threshold value, and is configured to calculate the final blood sugar level by decreasingly correcting the blood sugar concentration measurement, having been measured based on the Raman spectra, when the Hb concentration is less than the predetermined threshold value. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A noninvasive in vivo measuring system comprising:
-
a tissue modulation unit configured to apply a pressure on a tissue; a Hb measuring unit configured to analyze an amount of reflection of electromagnetic waves, having been irradiated on a first portion of a tissue, before and after the application of pressure by the tissue modulation unit, and measuring Hb concentration of the tissue; and an R-F measuring unit configured to measure Hb concentration of the tissue by analyzing Raman spectra of reflection of lasers, having been irradiated on a second portion of the tissue, before and after the application of pressure by the tissue modulation unit, and configured to calculate a final blood sugar level by increasingly or decreasingly correcting blood sugar concentration measurement according to the measured Hb concentration, wherein the Hb measuring unit is configured to identify differences of body fluids in a first portion of the tissue before and after the application of the pressure on the tissue using the reflection of the electromagnetic waves, and is configured to measure the Hb concentration by analyzing differences of absorption with respect to the identified differences of body fluids in the first portion of the tissue.
-
-
11. A noninvasive in vivo measuring method comprising:
-
analyzing an amount of absorption of electromagnetic waves on a first portion of a tissue; analyzing Raman spectra based on a reflection of a laser irradiated on a second portion of the tissue; using a tissue modulation unit to apply a pressure on the tissue; using a hemoglobin (Hb) measuring unit to analyze the amount of absorption of electromagnetic waves on the first portion of the tissue after the applying of the pressure; using a Raman-fluorescence (R-F) measuring unit to analyze the Raman spectra based on the reflection of the laser irradiated on the second portion of the tissue after the applying of the pressure; measuring Hb concentration of the tissue using a difference of the absorption of the electromagnetic waves on the first portion of the tissue before and after applying the pressure; measuring blood sugar concentration of the tissue using a difference of the Raman spectra on the second portion of the tissue before and after the applying of the pressure; and measuring a final blood sugar level by correcting the blood sugar concentration measurement according to the measured Hb concentration. - View Dependent Claims (12, 13, 14, 15, 16)
-
-
17. A noninvasive in vivo measuring method comprising:
-
analyzing an amount of reflection of electromagnetic waves on a first portion of a tissue; analyzing Raman spectra using reflection of lasers, having been irradiated on a second portion of the tissue; using a tissue modulation unit to apply a pressure on the tissue; using a hemoglobin (Hb) measuring unit to analyze an amount of reflection of electromagnetic waves on the first portion of the tissue before and after the applying of the pressure; using a Raman-fluorescence (R-F) measuring unit to analyze Raman spectra using reflection of lasers, having been irradiated on the second portion of the tissue before and after the applying of the pressure; measuring Hb concentration of the tissue using a difference of the amount of reflection of electromagnetic waves on the first portion of the tissue before and after the applying of the pressure; measuring blood sugar concentration of the tissue using a difference of the Raman spectra before and after the applying of the pressure; and calculating a final blood sugar level by increasingly or decreasingly correcting the measured blood sugar concentration according to the measured Hb concentration.
-
-
18. A non-transitory computer-readable storage medium storing a program for implementing a noninvasive in vivo measuring method, the method comprising:
-
analyzing an amount of absorption of electromagnetic waves on a first portion of a tissue; analyzing Raman spectra based on a reflection of a laser irradiated on a second portion of the tissue; applying a pressure on the tissue; analyzing the amount of absorption of electromagnetic waves on the first portion of the tissue after the applying of the pressure; analyzing the Raman spectra based on the reflection of the laser irradiated on the second portion of the tissue after the applying of the pressure; measuring Hb concentration of the tissue using a difference of the absorption of the electromagnetic waves on the first portion of the tissue before and after applying the pressure; measuring blood sugar concentration of the tissue using a difference of the Raman spectra on the second portion of the tissue before and after the applying of the pressure; and
measuring a final blood sugar level by correcting the blood sugar concentration measurement according to the measured Hb concentration.
-
Specification